Omega-3, Vitamin D, and the 'Aging Clock': What the DO-HEALTH Trial Found
A 2025 analysis of the large DO-HEALTH trial made headlines for finding that omega-3 — on its own, and more so combined with vitamin D and a simple home exercise program — slowed several "DNA-methylation aging clocks" in adults over 70. The effect was genuine but small, on the order of three months of "biological age" over three years, and here is the part the headlines skipped: the very same trial found these interventions did not reduce actual heart attacks, strokes, or new cases of high blood pressure. An aging clock is a promising research marker, not a proven health outcome, so the sensible reading is that omega-3 plus vitamin D plus light strength training is a low-risk, reasonable bundle for older adults for reasons we already knew — not because it has been shown to extend healthy life.
"Cheap supplements slow aging in a clinical trial" is exactly the kind of headline that moves bottles, and in 2025 the DO-HEALTH trial supplied one. The underlying science is real and worth understanding — but so is the gap between what the study measured and what the headlines implied. This is a useful case study in how to read a modern longevity finding.
What DO-HEALTH actually tested
DO-HEALTH was a well-designed European trial of 2,157 generally healthy adults aged 70 and older, using a 2×2×2 factorial design — meaning it tested three interventions and their combinations at once: 2,000 IU/day of vitamin D, 1 g/day of omega-3, and a simple home strength-exercise program done three times a week, all over three years [2]. That design is a strength: it lets researchers see each intervention's individual effect and whether combining them adds up.
The aging-clock result
In a 2025 analysis published in Nature Aging, researchers applied four "next-generation" DNA-methylation aging clocks (PhenoAge, GrimAge, GrimAge2, and DunedinPACE) to 777 participants [1]. Omega-3 on its own slowed three of the clocks, and all three interventions together produced an additive benefit on one of them (PhenoAge). The size of the effect was small: standardized changes of roughly 0.16 to 0.32 units, which the authors translated to about 2.9 to 3.8 months of biological aging slowed over the three years. So the direction is encouraging and the trial quality is high — but the magnitude is months, not years, and it shows up on a laboratory measure rather than in how people felt or functioned.
But the hard endpoints didn't move
Here is the context that reframes the headline. A separate DO-HEALTH analysis looking at cardiovascular outcomes found that neither omega-3, nor vitamin D, nor the exercise program reduced major cardiovascular events (heart attacks, heart failure, stroke) or the rate of new high blood pressure over the three years [2]. Omega-3 did change blood lipids, but with genuinely mixed effects: it raised HDL ("good") cholesterol and lowered triglycerides, yet also raised LDL ("bad") and total cholesterol. In other words, the same supplements that nudged an aging clock did not deliver the outcome — fewer cardiovascular events — that actually matters to a 75-year-old. That is not a contradiction so much as a reminder that a biomarker and a real-world outcome are different things.
What an "aging clock" is — and isn't
DNA-methylation clocks estimate biological age from chemical tags on DNA, and across large populations they do track aging and predict disease risk reasonably well. What they have not yet done is prove themselves as a treatment target: there is no established evidence that nudging a clock by a few months in a trial translates into more healthy years of life. The clock is a hypothesis-generating marker, useful for research, not a validated readout that a person is now meaningfully "younger." Treating a small clock change as if it were proof of life extension is the central leap the coverage made — and it is exactly the leap to be skeptical of.
Practical take
None of this is a reason to dismiss the bundle — it is a reason to value it for the right reasons. Omega-3 and vitamin D are low-risk, and for adults over 70, vitamin D plus omega-3 plus regular strength training already have a defensible evidence base for other endpoints (DO-HEALTH itself and earlier work have linked this combination to benefits like fewer falls and infections in some analyses). If you are an older adult taking this trio, the aging-clock result is a modest bonus signal, not the reason to do it; judge the regimen on function, falls, strength, and the advice of your clinician — and treat "slows aging" as a lab-marker headline that science has not yet cashed into extra healthy years.
Sources
- Bischoff-Ferrari HA, Gängler S, Wieczorek M, et al. "Individual and additive effects of vitamin D, omega-3 and exercise on DNA methylation clocks of biological aging in older adults from the DO-HEALTH trial." Nature Aging, 2025;5(3):376-385. PMID 39900648.
- Gaengler S, Sadlon A, De Godoi Rezende Costa Molino C, et al. "Effects of vitamin D, omega-3 and a simple strength exercise programme in cardiovascular disease prevention: The DO-HEALTH randomized controlled trial." The Journal of Nutrition, Health & Aging, 2024;28(2):100037. PMID 38199870.